Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on February 1, 2022, to report its financial results for the quarter and year ended December 31, 2021. The filing primarily directs investors to a press release (Exhibit 99.1) containing detailed financial information, including both GAAP and non-GAAP measures. Management emphasizes the utility of non-GAAP figures for internal operational planning and budgeting, and suggests investors review these alongside the official GAAP statements. A reconciliation between GAAP and non-GAAP figures is provided within the press release. Investors should note that the information furnished in this 8-K, including the press release, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and therefore does not carry the same liabilities. This filing serves as a notification of the release of earnings data, with the comprehensive details available in the accompanying press release. Key performance indicators and strategic updates are expected to be found within that document.
Key Highlights
- 1Gilead Sciences announced its financial results for the fourth quarter and full year ended December 31, 2021, via an 8-K filing on February 1, 2022.
- 2The filing incorporates a press release (Exhibit 99.1) detailing the company's financial performance.
- 3Both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial measures are presented in the press release.
- 4Management believes non-GAAP financial information is useful for investors, as it is used internally for operational and financial planning.
- 5A reconciliation between GAAP and non-GAAP financial figures is provided within the press release.
- 6The information furnished in the 8-K and press release is not considered "filed" under Section 18 of the Exchange Act.
- 7The Cover Page Interactive Data File is included as Exhibit 104.